Case number 2020-2074
Somaxon Pharmaceuticals Inc. v. Mylan Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 13, 2021 | 26 | ORDER granting motion [25] to the extent that the appeal is withdrawn. Each side shall bear its own costs. ISSUED AS A MANDATE: January 13, 2021. Service as of this date by the Clerk of Court. [749146] [LMS] [Entered: 01/13/2021 01:38 PM] (2) |
| Jan 11, 2021 | 23 | MOTION of Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 01/11/2021 by email. [748570] [20-2074] [Joshua Calabro] [Entered: 01/11/2021 07:03 PM] (9) |
| Jan 11, 2021 | 24 | Notice of Correction to Doc No. [23] for Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc.. Service: 01/11/2021 by email. [748582] [20-2074] [Joshua Calabro] [Entered: 01/11/2021 10:39 PM] (7) |
| Jan 11, 2021 | 25 | MOTION of Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 01/11/2021 by email. [748583] [20-2074] [Joshua Calabro] [Entered: 01/11/2021 10:41 PM] (9) |
| Dec 4, 2020 | 22 | ORDER granting motion to extend time to file brief [21] filed by Appellants. The opening brief is due 01/11/2021. The revised official caption and short caption are reflected in this order to indicate the non-participation of the Actavis entities. Service as of this date by the Clerk of Court. [740233] [LMS] [Entered: 12/04/2020 09:49 AM] (2) |
| Dec 2, 2020 | 21 | MOTION of Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc. to extend the time to 01/11/2021 to file brief. Service: 12/02/2020 by email. [739786] [20-2074] [Joshua Calabro] [Entered: 12/02/2020 05:44 PM] (13) |
| Nov 19, 2020 | 20 | ORDER modifying the official caption. The revised official caption is reflected in the order. Within 14 days from the date of filing of this order, counsel for Actavis Elizabeth LLC and Actavis Inc. are directed to file their entries of appearance or notices of non-participation in this appeal. Service as of this date by the Clerk of Court. [737097] [NL] [Entered: 11/19/2020 06:07 PM] (2) |
| Oct 28, 2020 | 19 | Notice from Appellant Procom One Inc. Notice for Non-Appearance. Service: 10/28/2020 by email. [732179] [20-2074] [Holly Tao] [Entered: 10/28/2020 05:55 PM] (1) |
| Oct 15, 2020 | 18 | ORDER filed denying [12] motion to dismiss. The parties are directed to address the jurisdiction issues in their briefs. Within 14 days from the date of filing of this order, counsel for ProCom One Inc., Actavis Elizabeth LLC, and Actavis Inc. are directed to file their entries of appearance or notices of non-participation in this appeal. The stay of the briefing schedule is lifted. Appellants’ opening brief is due no later than 60 days from the date of filing of this order. Service as of this date by the Clerk of Court. [729150] [NL] [Entered: 10/15/2020 03:57 PM] (2) |
| Sep 28, 2020 | 17 | Confidential Exhibit D filed by Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. corresponding to Doc. No. [16]. Service: 09/28/2020 by email. [724973] [20-2074] [Nicole Stafford] [Entered: 09/28/2020 09:07 PM] (0) |
| Sep 21, 2020 | 16 | REPLY of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. to response [15]. Service: 09/21/2020 by email. [723378] [20-2074] [Nicole Stafford] [Entered: 09/21/2020 06:55 PM] (35) |
| Sep 16, 2020 | 14 | Notice of Correction to Doc No. [13] for Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc.. Service: 09/16/2020 by email. [722231] [20-2074] [Dominick Conde] [Entered: 09/16/2020 04:23 PM] (7) |
| Sep 16, 2020 | 15 | RESPONSE of Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc. to the motion to terminate appeal [12]. Service: 09/16/2020 by email. [722245] [20-2074] [Dominick Conde] [Entered: 09/16/2020 04:33 PM] (19) |
| Sep 14, 2020 | 13 | RESPONSE of Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc. to the motion to terminate appeal [12]. Service: 09/14/2020 by email. [721456] [20-2074] [Dominick Conde] [Entered: 09/14/2020 05:22 PM] (36) |
| Sep 4, 2020 | 11 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc., Motion to Dismiss Appeal [10], is not in compliance with the rules of this court (see attached). Compliant document due on 09/14/2020. Service as of this date by the Clerk of Court. [719741] [KMH] [Entered: 09/04/2020 03:02 PM] (2) |
| Sep 4, 2020 | 12 | MOTION of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. to terminate appeal through Dismissal. Cases to be terminated: 20-2074. (Briefing suspended pursuant to FCR 31 pending resolution of the motion). [Consent: opposed]. Service: 09/04/2020 by email. [719859] [20-2074] [David Steuer] [Entered: 09/04/2020 07:11 PM] (60) |
| Sep 2, 2020 | 10 | MOTION of Appellee Mylan Inc. to terminate appeal through Dismissal. Cases to be terminated: 20-2074. (Briefing suspended pursuant to FCR 31 pending resolution of the motion). [Consent: opposed]. Service: 09/02/2020 by email. [719283] [20-2074] This document is non-compliant. See Doc No. [11] [David Steuer] [Entered: 09/02/2020 10:37 PM] (60) |
| Aug 21, 2020 | 9 | Notice to Appellant Procom One Inc. and Appellees Actavis Elizabeth LLC and Actavis Inc.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, or Docketing Statement under FCR 33.1(a) have been filed. Failure to file required documents may result in adverse action. See FCR 25(h). Service as of this date by the Clerk of Court. [716419] [KMH] [Entered: 08/21/2020 08:53 AM] (0) |
| Aug 12, 2020 | 7 | Official caption revised to add parties. (see attached). Service as of this date by the Clerk of Court. [714358] [KMH] [Entered: 08/12/2020 09:47 AM] (2) |
| Aug 12, 2020 | 8 | Docketing Statement for the Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 08/12/2020 by email. [714422] [20-2074] [David Steuer] [Entered: 08/12/2020 01:19 PM] (3) |
| Aug 11, 2020 | 2 | Entry of appearance for Dominick A. Conde; Christopher P. Borello; Joshua D. Calabro as counsel for Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc.. Service: 08/11/2020 by email. [714239] [20-2074] [Dominick Conde] [Entered: 08/11/2020 03:24 PM] (3) |
| Aug 11, 2020 | 3 | Certificate of Interest for Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc.. Service: 08/11/2020 by email. [714241] [20-2074] [Dominick Conde] [Entered: 08/11/2020 03:26 PM] (5) |
| Aug 11, 2020 | 4 | Docketing Statement for the Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc.. Service: 08/11/2020 by email. [714242] [20-2074] [Dominick Conde] [Entered: 08/11/2020 03:30 PM] (3) |
| Aug 11, 2020 | 5 | Entry of appearance for David S. Steuer as counsel for Mylan Inc.; Mylan Pharmaceuticals, Inc.. Service: 08/11/2020 by email. [714294] [20-2074] [David Steuer] [Entered: 08/11/2020 06:03 PM] (3) |
| Aug 11, 2020 | 6 | Certificate of Interest for Mylan Inc.; Mylan Pharmaceuticals, Inc.. Service: 08/11/2020 by email. [714295] [20-2074] [David Steuer] [Entered: 08/11/2020 06:11 PM] (5) |
| Jul 28, 2020 | 1 | Appeal docketed. Received: 07/24/2020. [710509]Entry of Appearance is due on 08/11/2020. Certificate of Interest is due on 08/11/2020. Docketing Statement is due on 08/11/2020. Appellant's brief is due on 09/28/2020. [KMH] [Entered: 07/28/2020 09:23 AM] (57) |
